Labadan, Baby Boy .

HRN: 25-67-83  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
AMPICILLIN 500MG (VIAL)
10/10/2024
10/17/2024
IV
165mg
Q12h
Sepsis
Waiting Final Action 
10/10/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
10/10/2024
10/17/2024
IV
16.5mg
Q24h
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: